Abrogation of the interaction between osteopontin and αvβ3 integrin reduces tumor growth of human lung cancer cells in mice

References

Page 1

	Year	Citations
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Arindam Bhattacharjee, William G. Richards, Jane Staunton, Proceedings of the National Academy of Sciences EngineeringPathologyCancer DeathCancer BiologyGene Expression Profiling	2001	2.6K
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1) Georg F. Weber, Samy Ashkar, Melvin J. Glimcher, Science SclerostinBone Morphogenic ProteinMedicineCell AdhesionImmunology	1996	941
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. Peter C. Brooks, Staffan Strömblad, Richard Klemke, Journal of Clinical Investigation	1995	829
Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Donald R. Senger, Stephen Ledbetter, Kevin P. Claffey, PubMed	1996	552
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer Jae‐Hoon Kim JAMA	2002	504
Osteopontin Identified as Lead Marker of Colon Cancer Progression, Using Pooled Sample Expression Profiling Deepak Agrawal JNCI Journal of the National Cancer Institute	2002	426
Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. J. Gutheil, Tanya Campbell, Paul R. Pierce, PubMed Tumor BiologyEndothelial CellsIntegrin Alphavbeta3MedicineImmunology	2000	370
Osteopontin expression and distribution in human carcinomas. Lawrence F. Brown, A Papadopoulos-Sergiou, Brygida Berse, PubMed	1994	328
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Giampietro Gasparini, Peter C. Brooks, Elia Biganzoli, PubMed Vascular Integrin AlphaBreast OncologyAngiogenesisMedicineImmunology	1998	280
Osteopontin: possible role in prostate cancer progression. George N. Thalmann, Robert A. Sikes, Robert E. Devoll, PubMed Hopn AntibodyUrologyBone Morphogenic ProteinHopn MrnaHuman Opn	1999	263

Page 1